Inhibition of Fas-associated death domain-containing protein (FADD) protects against myocardial ischemia/reperfusion injury in a heart failure mouse model.
As technological interventions treating acute myocardial infarction (MI) improve, post-ischemic heart failure increasingly threatens patient health. The aim of the current study was to test whether FADD could be a potential target of gene therapy in the treatment of heart failure.Cardiomyocyte-speci...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3772851?pdf=render |
id |
doaj-27ed734ee9b24f058525a0b192b4dc4e |
---|---|
record_format |
Article |
spelling |
doaj-27ed734ee9b24f058525a0b192b4dc4e2020-11-25T02:15:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0189e7353710.1371/journal.pone.0073537Inhibition of Fas-associated death domain-containing protein (FADD) protects against myocardial ischemia/reperfusion injury in a heart failure mouse model.Qian FanZheng M HuangMatthieu BoucherXiying ShangLin ZuoHenriette BrinksWayne Bond LauJianke ZhangJ Kurt ChuprunErhe GaoAs technological interventions treating acute myocardial infarction (MI) improve, post-ischemic heart failure increasingly threatens patient health. The aim of the current study was to test whether FADD could be a potential target of gene therapy in the treatment of heart failure.Cardiomyocyte-specific FADD knockout mice along with non-transgenic littermates (NLC) were subjected to 30 minutes myocardial ischemia followed by 7 days of reperfusion or 6 weeks of permanent myocardial ischemia via the ligation of left main descending coronary artery. Cardiac function were evaluated by echocardiography and left ventricular (LV) catheterization and cardiomyocyte death was measured by Evans blue-TTC staining, TUNEL staining, and caspase-3, -8, and -9 activities. In vitro, H9C2 cells transfected with ether scramble siRNA or FADD siRNA were stressed with chelerythrin for 30 min and cleaved caspase-3 was assessed.FADD expression was significantly decreased in FADD knockout mice compared to NLC. Ischemia/reperfusion (I/R) upregulated FADD expression in NLC mice, but not in FADD knockout mice at the early time. FADD deletion significantly attenuated I/R-induced cardiac dysfunction, decreased myocardial necrosis, and inhibited cardiomyocyte apoptosis. Furthermore, in 6 weeks long term permanent ischemia model, FADD deletion significantly reduced the infarct size (from 41.20 ± 3.90% in NLC to 26.83 ± 4.17% in FADD deletion), attenuated myocardial remodeling, improved cardiac function and improved survival. In vitro, FADD knockdown significantly reduced chelerythrin-induced the level of cleaved caspase-3.Taken together, our results suggest FADD plays a critical role in post-ischemic heart failure. Inhibition of FADD retards heart failure progression. Our data supports the further investigation of FADD as a potential target for genetic manipulation in the treatment of heart failure.http://europepmc.org/articles/PMC3772851?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Qian Fan Zheng M Huang Matthieu Boucher Xiying Shang Lin Zuo Henriette Brinks Wayne Bond Lau Jianke Zhang J Kurt Chuprun Erhe Gao |
spellingShingle |
Qian Fan Zheng M Huang Matthieu Boucher Xiying Shang Lin Zuo Henriette Brinks Wayne Bond Lau Jianke Zhang J Kurt Chuprun Erhe Gao Inhibition of Fas-associated death domain-containing protein (FADD) protects against myocardial ischemia/reperfusion injury in a heart failure mouse model. PLoS ONE |
author_facet |
Qian Fan Zheng M Huang Matthieu Boucher Xiying Shang Lin Zuo Henriette Brinks Wayne Bond Lau Jianke Zhang J Kurt Chuprun Erhe Gao |
author_sort |
Qian Fan |
title |
Inhibition of Fas-associated death domain-containing protein (FADD) protects against myocardial ischemia/reperfusion injury in a heart failure mouse model. |
title_short |
Inhibition of Fas-associated death domain-containing protein (FADD) protects against myocardial ischemia/reperfusion injury in a heart failure mouse model. |
title_full |
Inhibition of Fas-associated death domain-containing protein (FADD) protects against myocardial ischemia/reperfusion injury in a heart failure mouse model. |
title_fullStr |
Inhibition of Fas-associated death domain-containing protein (FADD) protects against myocardial ischemia/reperfusion injury in a heart failure mouse model. |
title_full_unstemmed |
Inhibition of Fas-associated death domain-containing protein (FADD) protects against myocardial ischemia/reperfusion injury in a heart failure mouse model. |
title_sort |
inhibition of fas-associated death domain-containing protein (fadd) protects against myocardial ischemia/reperfusion injury in a heart failure mouse model. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
As technological interventions treating acute myocardial infarction (MI) improve, post-ischemic heart failure increasingly threatens patient health. The aim of the current study was to test whether FADD could be a potential target of gene therapy in the treatment of heart failure.Cardiomyocyte-specific FADD knockout mice along with non-transgenic littermates (NLC) were subjected to 30 minutes myocardial ischemia followed by 7 days of reperfusion or 6 weeks of permanent myocardial ischemia via the ligation of left main descending coronary artery. Cardiac function were evaluated by echocardiography and left ventricular (LV) catheterization and cardiomyocyte death was measured by Evans blue-TTC staining, TUNEL staining, and caspase-3, -8, and -9 activities. In vitro, H9C2 cells transfected with ether scramble siRNA or FADD siRNA were stressed with chelerythrin for 30 min and cleaved caspase-3 was assessed.FADD expression was significantly decreased in FADD knockout mice compared to NLC. Ischemia/reperfusion (I/R) upregulated FADD expression in NLC mice, but not in FADD knockout mice at the early time. FADD deletion significantly attenuated I/R-induced cardiac dysfunction, decreased myocardial necrosis, and inhibited cardiomyocyte apoptosis. Furthermore, in 6 weeks long term permanent ischemia model, FADD deletion significantly reduced the infarct size (from 41.20 ± 3.90% in NLC to 26.83 ± 4.17% in FADD deletion), attenuated myocardial remodeling, improved cardiac function and improved survival. In vitro, FADD knockdown significantly reduced chelerythrin-induced the level of cleaved caspase-3.Taken together, our results suggest FADD plays a critical role in post-ischemic heart failure. Inhibition of FADD retards heart failure progression. Our data supports the further investigation of FADD as a potential target for genetic manipulation in the treatment of heart failure. |
url |
http://europepmc.org/articles/PMC3772851?pdf=render |
work_keys_str_mv |
AT qianfan inhibitionoffasassociateddeathdomaincontainingproteinfaddprotectsagainstmyocardialischemiareperfusioninjuryinaheartfailuremousemodel AT zhengmhuang inhibitionoffasassociateddeathdomaincontainingproteinfaddprotectsagainstmyocardialischemiareperfusioninjuryinaheartfailuremousemodel AT matthieuboucher inhibitionoffasassociateddeathdomaincontainingproteinfaddprotectsagainstmyocardialischemiareperfusioninjuryinaheartfailuremousemodel AT xiyingshang inhibitionoffasassociateddeathdomaincontainingproteinfaddprotectsagainstmyocardialischemiareperfusioninjuryinaheartfailuremousemodel AT linzuo inhibitionoffasassociateddeathdomaincontainingproteinfaddprotectsagainstmyocardialischemiareperfusioninjuryinaheartfailuremousemodel AT henriettebrinks inhibitionoffasassociateddeathdomaincontainingproteinfaddprotectsagainstmyocardialischemiareperfusioninjuryinaheartfailuremousemodel AT waynebondlau inhibitionoffasassociateddeathdomaincontainingproteinfaddprotectsagainstmyocardialischemiareperfusioninjuryinaheartfailuremousemodel AT jiankezhang inhibitionoffasassociateddeathdomaincontainingproteinfaddprotectsagainstmyocardialischemiareperfusioninjuryinaheartfailuremousemodel AT jkurtchuprun inhibitionoffasassociateddeathdomaincontainingproteinfaddprotectsagainstmyocardialischemiareperfusioninjuryinaheartfailuremousemodel AT erhegao inhibitionoffasassociateddeathdomaincontainingproteinfaddprotectsagainstmyocardialischemiareperfusioninjuryinaheartfailuremousemodel |
_version_ |
1724896280453316608 |